Indocyanine Green is a dye used to help doctors see blood flow and take better images during eye exams and certain surgical procedures. It's injected into the bloodstream and shows up brightly under special infrared light, allowing doctors to visualize blood vessels and tissues.[2] IC-Green is currently approved and in use across 53 indications[4].[1]
IC-Green is one of 828 small molecule programs targeting Head and Neck Carcinoma. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
2828 competitors in Breast Cancer
IC-Green
Tecentriq
Zinecard
Chirocaine
Feraheme
Vfend
Neoadjuvant Therapy
Metfomin
Diuretic
Bisphosphonate
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
IC-GREEN
NDA NDA011525
Nov 21, 2018
SPY AGENT GREEN KIT
NDA NDA211580
Sources
Details